- 8.28.2025
- Blog
Beyond the One Dose Wonder: Why Psychedelic Clinical Trial Protocols Must Evolve Beyond Academic Norms
When most people hear about psychedelic clinical trials, they envision a single, transformative session, maybe two, resulting in rapid, life-changing outcomes. But the reality is more complex.
- 8.19.2025
- Blog
Hope Has Data: The Science Behind Psychedelic Healing for Veterans
This blog explores the growing body of evidence supporting psychedelic-assisted therapy as a powerful, trauma-informed treatment option for veterans with PTSD and TBI. Highlighting data, personal stories, and VETS’ commitment to research and access, it underscores how science and compassion are transforming the future of healing.
Stepping Into Service: A Note from Our New Director of Research
John Clifton, M.D., the new Director of Research at VETS, brings a decade of experience in psychedelic healing and a vision for advancing safe, trauma-informed, and evidence-based therapies for veterans. In this welcome message, he shares his reflections on the state of the field, the urgent need for research and policy reform, and his commitment to empowering community-driven learning.
- 8.1.2025
- Blog
Freedom to Heal: What It Means And Why We’re Fighting For It
At VETS, we believe that healing is a right, not a privilege. That’s what we mean by Freedom to Heal. It’s not just a phrase. It’s a promise. And it’s the driving force behind everything we do.
- 7.8.2025
- Blog
A New Hope for Healing: Psilocybin Clinical Trial Now Open to Veterans
Thanks to the recent passage of SB5263, Washington State is developing a robust legal framework for Washington residents over the age of 21 to access psilocybin services. With it comes a clinical trial designed specifically for U.S. veterans.